APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mydriatic Eyedrops

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mydriatic Eyedrops Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174015230319 December 2025197 pages

Choose your research edition.

Industry ResearchMydriatic Eyedrops Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Mydriatic Eyedrops Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Mydriatic Eyedrops Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mydriatic Eyedrops Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Mydriatic Eyedrops Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Mydriatic Eyedrops market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mydriatic Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mydriatic Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mydriatic Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mydriatic Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mydriatic Eyedrops include Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon and Viva Opti-Free, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mydriatic Eyedrops market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mydriatic Eyedrops and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mydriatic Eyedrops sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mydriatic Eyedrops market size, projected growth trends, production technologies, key applications, and end-use industries.

Mydriatic Eyedrops Segment by Company

Novartis AG

Allergan, Inc.

Meda Pharmaceuticals Inc

Bausch & Lomb Inc

Cigna

Similasan Corporation

Visine

Alcon

Viva Opti-Free

Bausch & Lomb

Systane

Rite Aid

Walgreens

Staples

Clear eyes

Mydriatic Eyedrops Segment by Type

Atropine

Homatropine

Dolly

Others

Mydriatic Eyedrops Segment by Application

Adult

Children

Mydriatic Eyedrops Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mydriatic Eyedrops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mydriatic Eyedrops and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mydriatic Eyedrops.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mydriatic Eyedrops market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mydriatic Eyedrops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mydriatic Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mydriatic Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mydriatic Eyedrops Industry Trends Table 2. Mydriatic Eyedrops Industry Drivers Table 3. Mydriatic Eyedrops Industry Opportunities and Challenges Table 4. Mydriatic Eyedrops Industry Restraints Table 5. Global Mydriatic Eyedrops Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mydriatic Eyedrops Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mydriatic Eyedrops Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Mydriatic Eyedrops Sales Market Share by Manufacturers Table 9. Global Mydriatic Eyedrops Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Mydriatic Eyedrops Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mydriatic Eyedrops Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mydriatic Eyedrops Manufacturers, Product Type & Application Table 13. Global Mydriatic Eyedrops Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mydriatic Eyedrops by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Atropine Table 17. Major Manufacturers of Homatropine Table 18. Major Manufacturers of Dolly Table 19. Major Manufacturers of Others Table 20. Global Mydriatic Eyedrops Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Mydriatic Eyedrops Sales by Type (2021-2026) & (W Units) Table 22. Global Mydriatic Eyedrops Sales by Type (2027-2032) & (W Units) Table 23. Global Mydriatic Eyedrops Sales Market Share by Type (2021-2026) Table 24. Global Mydriatic Eyedrops Sales Market Share by Type (2027-2032) Table 25. Global Mydriatic Eyedrops Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Mydriatic Eyedrops Revenue by Type (2021-2026) & (W Units) Table 27. Global Mydriatic Eyedrops Revenue by Type (2027-2032) & (W Units) Table 28. Global Mydriatic Eyedrops Revenue Market Share by Type (2021-2026) Table 29. Global Mydriatic Eyedrops Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Adult Table 31. Major Manufacturers of Children Table 32. Global Mydriatic Eyedrops Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Mydriatic Eyedrops Sales by Application (2021-2026) & (W Units) Table 34. Global Mydriatic Eyedrops Sales by Application (2027-2032) & (W Units) Table 35. Global Mydriatic Eyedrops Sales Market Share by Application (2021-2026) Table 36. Global Mydriatic Eyedrops Sales Market Share by Application (2027-2032) Table 37. Global Mydriatic Eyedrops Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Mydriatic Eyedrops Revenue by Application (2021-2026) & (W Units) Table 39. Global Mydriatic Eyedrops Revenue by Application (2027-2032) & (W Units) Table 40. Global Mydriatic Eyedrops Revenue Market Share by Application (2021-2026) Table 41. Global Mydriatic Eyedrops Revenue Market Share by Application (2027-2032) Table 42. Global Mydriatic Eyedrops Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Mydriatic Eyedrops Sales by Region (2021-2026) & (W Units) Table 44. Global Mydriatic Eyedrops Sales Market Share by Region (2021-2026) Table 45. Global Mydriatic Eyedrops Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Mydriatic Eyedrops Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Mydriatic Eyedrops Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 49. North America Mydriatic Eyedrops Sales by Country (2027-2032) & (W Units) Table 50. Europe Mydriatic Eyedrops Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 52. Europe Mydriatic Eyedrops Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Mydriatic Eyedrops Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Mydriatic Eyedrops Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Mydriatic Eyedrops Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Mydriatic Eyedrops Sales by Country (2027-2032) & (W Units) Table 59. Global Mydriatic Eyedrops Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Mydriatic Eyedrops Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Mydriatic Eyedrops Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Mydriatic Eyedrops Revenue Market Share by Region (2021-2026) Table 63. Global Mydriatic Eyedrops Revenue Market Share by Region (2027-2032) Table 64. Novartis AG Company Information Table 65. Novartis AG Business Overview Table 66. Novartis AG Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Novartis AG Mydriatic Eyedrops Product Portfolio Table 68. Novartis AG Recent Development Table 69. Allergan, Inc. Company Information Table 70. Allergan, Inc. Business Overview Table 71. Allergan, Inc. Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Allergan, Inc. Mydriatic Eyedrops Product Portfolio Table 73. Allergan, Inc. Recent Development Table 74. Meda Pharmaceuticals Inc Company Information Table 75. Meda Pharmaceuticals Inc Business Overview Table 76. Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Meda Pharmaceuticals Inc Mydriatic Eyedrops Product Portfolio Table 78. Meda Pharmaceuticals Inc Recent Development Table 79. Bausch & Lomb Inc Company Information Table 80. Bausch & Lomb Inc Business Overview Table 81. Bausch & Lomb Inc Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bausch & Lomb Inc Mydriatic Eyedrops Product Portfolio Table 83. Bausch & Lomb Inc Recent Development Table 84. Cigna Company Information Table 85. Cigna Business Overview Table 86. Cigna Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Cigna Mydriatic Eyedrops Product Portfolio Table 88. Cigna Recent Development Table 89. Similasan Corporation Company Information Table 90. Similasan Corporation Business Overview Table 91. Similasan Corporation Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Similasan Corporation Mydriatic Eyedrops Product Portfolio Table 93. Similasan Corporation Recent Development Table 94. Visine Company Information Table 95. Visine Business Overview Table 96. Visine Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Visine Mydriatic Eyedrops Product Portfolio Table 98. Visine Recent Development Table 99. Alcon Company Information Table 100. Alcon Business Overview Table 101. Alcon Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Alcon Mydriatic Eyedrops Product Portfolio Table 103. Alcon Recent Development Table 104. Viva Opti-Free Company Information Table 105. Viva Opti-Free Business Overview Table 106. Viva Opti-Free Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Viva Opti-Free Mydriatic Eyedrops Product Portfolio Table 108. Viva Opti-Free Recent Development Table 109. Bausch & Lomb Company Information Table 110. Bausch & Lomb Business Overview Table 111. Bausch & Lomb Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Bausch & Lomb Mydriatic Eyedrops Product Portfolio Table 113. Bausch & Lomb Recent Development Table 114. Systane Company Information Table 115. Systane Business Overview Table 116. Systane Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Systane Mydriatic Eyedrops Product Portfolio Table 118. Systane Recent Development Table 119. Rite Aid Company Information Table 120. Rite Aid Business Overview Table 121. Rite Aid Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Rite Aid Mydriatic Eyedrops Product Portfolio Table 123. Rite Aid Recent Development Table 124. Walgreens Company Information Table 125. Walgreens Business Overview Table 126. Walgreens Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Walgreens Mydriatic Eyedrops Product Portfolio Table 128. Walgreens Recent Development Table 129. Staples Company Information Table 130. Staples Business Overview Table 131. Staples Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Staples Mydriatic Eyedrops Product Portfolio Table 133. Staples Recent Development Table 134. Clear eyes Company Information Table 135. Clear eyes Business Overview Table 136. Clear eyes Mydriatic Eyedrops Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Clear eyes Mydriatic Eyedrops Product Portfolio Table 138. Clear eyes Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Mydriatic Eyedrops Distributors List Table 142. Mydriatic Eyedrops Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Mydriatic Eyedrops Product Image Figure 2. Global Mydriatic Eyedrops Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mydriatic Eyedrops Market Size (2021-2032) & (US$ Million) Figure 4. Global Mydriatic Eyedrops Sales (2021-2032) & (W Units) Figure 5. Global Mydriatic Eyedrops Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mydriatic Eyedrops Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Atropine Image Figure 9. Homatropine Image Figure 10. Dolly Image Figure 11. Others Image Figure 12. Global Mydriatic Eyedrops Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Mydriatic Eyedrops Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Mydriatic Eyedrops Sales Market Share by Type (2021-2032) Figure 15. Global Mydriatic Eyedrops Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Mydriatic Eyedrops Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Mydriatic Eyedrops Revenue Market Share by Type (2021-2032) Figure 18. Adult Image Figure 19. Children Image Figure 20. Global Mydriatic Eyedrops Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Mydriatic Eyedrops Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Mydriatic Eyedrops Sales Market Share by Application (2021-2032) Figure 23. Global Mydriatic Eyedrops Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Mydriatic Eyedrops Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Mydriatic Eyedrops Revenue Market Share by Application (2021-2032) Figure 26. North America Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Mydriatic Eyedrops Sales Market Share by Country (2021-2032) Figure 28. U.S. Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Mydriatic Eyedrops Sales Market Share by Country (2021-2032) Figure 33. Germany Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Mydriatic Eyedrops Sales Market Share by Country (2021-2032) Figure 40. China Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Mydriatic Eyedrops Sales Market Share by Country (2021-2032) Figure 48. Brazil Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Mydriatic Eyedrops Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Mydriatic Eyedrops Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Mydriatic Eyedrops Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Mydriatic Eyedrops Revenue (2021-2032) & (US$ Million) Figure 59. North America Mydriatic Eyedrops Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Mydriatic Eyedrops Revenue (2021-2032) & (US$ Million) Figure 61. Europe Mydriatic Eyedrops Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Mydriatic Eyedrops Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Mydriatic Eyedrops Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Mydriatic Eyedrops Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Mydriatic Eyedrops Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Mydriatic Eyedrops Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Mydriatic Eyedrops Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Atropine
  • Homatropine
  • Dolly
  • Others
Applications
  • Adult
  • Children
Companies covered
  • Novartis AG
  • Allergan, Inc.
  • Meda Pharmaceuticals Inc
  • Bausch & Lomb Inc
  • Cigna
  • Similasan Corporation
  • Visine
  • Alcon
  • Viva Opti-Free
  • Bausch & Lomb
  • Systane
  • Rite Aid
  • Walgreens
  • Staples
  • Clear eyes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mydriatic Eyedrops Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mydriatic Eyedrops Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mydriatic Eyedrops Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mydriatic Eyedrops Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mydriatic Eyedrops Market Dynamics
  1. 2.1 Mydriatic Eyedrops Industry Trends
  2. 2.2 Mydriatic Eyedrops Industry Drivers
  3. 2.3 Mydriatic Eyedrops Industry Opportunities and Challenges
  4. 2.4 Mydriatic Eyedrops Industry Restraints
3 Mydriatic Eyedrops Market by Manufacturers
  1. 3.1 Global Mydriatic Eyedrops Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mydriatic Eyedrops Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mydriatic Eyedrops Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mydriatic Eyedrops Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mydriatic Eyedrops Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mydriatic Eyedrops Manufacturers, Product Type & Application
  7. 3.7 Global Mydriatic Eyedrops Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mydriatic Eyedrops Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mydriatic Eyedrops Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mydriatic Eyedrops Tier 1, Tier 2, and Tier 3
4 Mydriatic Eyedrops Market by Type
  1. 4.1 Mydriatic Eyedrops Type Introduction
  2. 4.1.1 Atropine
  3. 4.1.2 Homatropine
  4. 4.1.3 Dolly
  5. 4.1.4 Others
  6. 4.2 Global Mydriatic Eyedrops Sales by Type
  7. 4.2.1 Global Mydriatic Eyedrops Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Mydriatic Eyedrops Sales by Type (2021-2032)
  9. 4.2.3 Global Mydriatic Eyedrops Sales Market Share by Type (2021-2032)
  10. 4.3 Global Mydriatic Eyedrops Revenue by Type
  11. 4.3.1 Global Mydriatic Eyedrops Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Mydriatic Eyedrops Revenue by Type (2021-2032)
  13. 4.3.3 Global Mydriatic Eyedrops Revenue Market Share by Type (2021-2032)
5 Mydriatic Eyedrops Market by Application
  1. 5.1 Mydriatic Eyedrops Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Mydriatic Eyedrops Sales by Application
  5. 5.2.1 Global Mydriatic Eyedrops Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Mydriatic Eyedrops Sales by Application (2021-2032)
  7. 5.2.3 Global Mydriatic Eyedrops Sales Market Share by Application (2021-2032)
  8. 5.3 Global Mydriatic Eyedrops Revenue by Application
  9. 5.3.1 Global Mydriatic Eyedrops Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Mydriatic Eyedrops Revenue by Application (2021-2032)
  11. 5.3.3 Global Mydriatic Eyedrops Revenue Market Share by Application (2021-2032)
6 Global Mydriatic Eyedrops Sales by Region
  1. 6.1 Global Mydriatic Eyedrops Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mydriatic Eyedrops Sales by Region (2021-2032)
  3. 6.2.1 Global Mydriatic Eyedrops Sales by Region (2021-2026)
  4. 6.2.2 Global Mydriatic Eyedrops Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mydriatic Eyedrops Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mydriatic Eyedrops Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mydriatic Eyedrops Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mydriatic Eyedrops Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mydriatic Eyedrops Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mydriatic Eyedrops Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mydriatic Eyedrops Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mydriatic Eyedrops Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mydriatic Eyedrops Revenue by Region
  1. 7.1 Global Mydriatic Eyedrops Revenue by Region
  2. 7.1.1 Global Mydriatic Eyedrops Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mydriatic Eyedrops Revenue by Region (2021-2026)
  4. 7.1.3 Global Mydriatic Eyedrops Revenue by Region (2027-2032)
  5. 7.1.4 Global Mydriatic Eyedrops Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mydriatic Eyedrops Revenue (2021-2032)
  8. 7.2.2 North America Mydriatic Eyedrops Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mydriatic Eyedrops Revenue (2021-2032)
  11. 7.3.2 Europe Mydriatic Eyedrops Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mydriatic Eyedrops Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mydriatic Eyedrops Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mydriatic Eyedrops Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mydriatic Eyedrops Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Mydriatic Eyedrops Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Allergan, Inc.
  8. 8.2.1 Allergan, Inc. Company Information
  9. 8.2.2 Allergan, Inc. Business Overview
  10. 8.2.3 Allergan, Inc. Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Allergan, Inc. Mydriatic Eyedrops Product Portfolio
  12. 8.2.5 Allergan, Inc. Recent Developments
  13. 8.3 Meda Pharmaceuticals Inc
  14. 8.3.1 Meda Pharmaceuticals Inc Company Information
  15. 8.3.2 Meda Pharmaceuticals Inc Business Overview
  16. 8.3.3 Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Meda Pharmaceuticals Inc Mydriatic Eyedrops Product Portfolio
  18. 8.3.5 Meda Pharmaceuticals Inc Recent Developments
  19. 8.4 Bausch & Lomb Inc
  20. 8.4.1 Bausch & Lomb Inc Company Information
  21. 8.4.2 Bausch & Lomb Inc Business Overview
  22. 8.4.3 Bausch & Lomb Inc Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bausch & Lomb Inc Mydriatic Eyedrops Product Portfolio
  24. 8.4.5 Bausch & Lomb Inc Recent Developments
  25. 8.5 Cigna
  26. 8.5.1 Cigna Company Information
  27. 8.5.2 Cigna Business Overview
  28. 8.5.3 Cigna Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cigna Mydriatic Eyedrops Product Portfolio
  30. 8.5.5 Cigna Recent Developments
  31. 8.6 Similasan Corporation
  32. 8.6.1 Similasan Corporation Company Information
  33. 8.6.2 Similasan Corporation Business Overview
  34. 8.6.3 Similasan Corporation Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Similasan Corporation Mydriatic Eyedrops Product Portfolio
  36. 8.6.5 Similasan Corporation Recent Developments
  37. 8.7 Visine
  38. 8.7.1 Visine Company Information
  39. 8.7.2 Visine Business Overview
  40. 8.7.3 Visine Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Visine Mydriatic Eyedrops Product Portfolio
  42. 8.7.5 Visine Recent Developments
  43. 8.8 Alcon
  44. 8.8.1 Alcon Company Information
  45. 8.8.2 Alcon Business Overview
  46. 8.8.3 Alcon Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Alcon Mydriatic Eyedrops Product Portfolio
  48. 8.8.5 Alcon Recent Developments
  49. 8.9 Viva Opti-Free
  50. 8.9.1 Viva Opti-Free Company Information
  51. 8.9.2 Viva Opti-Free Business Overview
  52. 8.9.3 Viva Opti-Free Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Viva Opti-Free Mydriatic Eyedrops Product Portfolio
  54. 8.9.5 Viva Opti-Free Recent Developments
  55. 8.10 Bausch & Lomb
  56. 8.10.1 Bausch & Lomb Company Information
  57. 8.10.2 Bausch & Lomb Business Overview
  58. 8.10.3 Bausch & Lomb Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bausch & Lomb Mydriatic Eyedrops Product Portfolio
  60. 8.10.5 Bausch & Lomb Recent Developments
  61. 8.11 Systane
  62. 8.11.1 Systane Company Information
  63. 8.11.2 Systane Business Overview
  64. 8.11.3 Systane Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Systane Mydriatic Eyedrops Product Portfolio
  66. 8.11.5 Systane Recent Developments
  67. 8.12 Rite Aid
  68. 8.12.1 Rite Aid Company Information
  69. 8.12.2 Rite Aid Business Overview
  70. 8.12.3 Rite Aid Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Rite Aid Mydriatic Eyedrops Product Portfolio
  72. 8.12.5 Rite Aid Recent Developments
  73. 8.13 Walgreens
  74. 8.13.1 Walgreens Company Information
  75. 8.13.2 Walgreens Business Overview
  76. 8.13.3 Walgreens Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Walgreens Mydriatic Eyedrops Product Portfolio
  78. 8.13.5 Walgreens Recent Developments
  79. 8.14 Staples
  80. 8.14.1 Staples Company Information
  81. 8.14.2 Staples Business Overview
  82. 8.14.3 Staples Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Staples Mydriatic Eyedrops Product Portfolio
  84. 8.14.5 Staples Recent Developments
  85. 8.15 Clear eyes
  86. 8.15.1 Clear eyes Company Information
  87. 8.15.2 Clear eyes Business Overview
  88. 8.15.3 Clear eyes Mydriatic Eyedrops Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Clear eyes Mydriatic Eyedrops Product Portfolio
  90. 8.15.5 Clear eyes Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mydriatic Eyedrops Value Chain Analysis
  2. 9.1.1 Mydriatic Eyedrops Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mydriatic Eyedrops Production Mode & Process
  6. 9.2 Mydriatic Eyedrops Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mydriatic Eyedrops Distributors
  9. 9.2.3 Mydriatic Eyedrops Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst